University of Thessaly (UTH)
Συσχέτιση γενετικών παραγόντων και κλινικών παραμέτρων στην εμφάνιση οστεοπόρωσης
Abstract
dc:descriptionOsteoporosis and related fractures can cause permanent disability or death,require long rehabilitation and are considered an important cause of morbidity, mortality, imposing a great burden on health systems worldwide. Osteoporosis is usually diagnosed late in the course of the disease due to the asymptomatic nature of the disease and the lack of adequate screening programs. The increasing prevalence of osteoporosis and the lack of early diagnosis of the disease prior to the occurance of the first osteoporotic fracture emphasizes the need for effective strategies to screen and manage individuals with osteoporosis. To this end, it is important to understand the multifactorial nature of the disease and define the role of environmental and genetic factors in the pathogenesis of osteoporosis. In the present study, we evaluated the role of genetic factors in the regulation of bone density and metabolism, as well as the possible association between the mand various environmental factors in osteoporosis. Specifically, we studied gene polymorphisms and expression in peripheral blood and bone, biological markers of bone formation and resorption, as well as clinical parameters in an effort to correlate clinical phenotype with the expression patterns of important signaling pathways. The study was conducted in the Department of Orthopedic Surgery of the University Hospital of Larisa, Greece. Samples were assigned to the “osteoporotic patients” or “control” group, based on the diagnosis of osteoporosis, determined by medical history and DEXA findings. The following parameters were studied: a) known risk factors for osteoporosis, including non-modifiable risk factors, concomitant diseases, medications and lifestyle, b) X-rays and bone mineral density (BMD) measurements with DEXA, c) biochemical markers of bone metabolism (PTH, Calcitonin, Osteocalcin, Leptin, IGF), and d) gene expression of RUNX-2, FST,ITGB5, SOX-4 and SMAD1, as well as polymorphisms of CER1 and DKK1. The first section of the thesis is focused on clinical results and analyses in subgroups of patients with osteoporosis and/or osteoporotic fractures. The most important finding was the observed under diagnosis and under treatment of osteoporosis in patients >45 years of age with history of osteoporotic fractures of the hip, spine or distal radius, despite the fact that the majority of them had at least oneknown risk factor for osteoporosis. Age, sex, family history of osteoporosis and history of previous osteoporotic fractures seemed to affect the healthcare providers’ decision to screen/treat for osteoporosis. Furthermore, we evaluated the phenomenon of T-score discordance between hip and spine measurements in the diagnosis of osteoporosis (minor: 46%, major: 8% in our study), as well as the relationship between osteoarthritis and osteoporosis in patients with osteoporotic hip fractures. Our data showed that osteoarthritis doesn’t reduce the risk of hip fractures. The second part of the present thesis is focused on genetic profile analyses. Comparison between osteoporotic patients and controls showed significant differences in the three polymoprhisms of CER1, with osteoporotic patients presenting with an increased frequency of the abnormal alleles. The presence of at least one risk factor for osteoporosis was more frequent in patients with the normal allele compared to the abnormal allele for all CER1 polymorphisms. Additionally, the presence of the abnormal genotype of CER1 polymophisms in patients with osteoporosis was correlated with increased risk of osteoporotic fractures, as well as higher levels of serum osteocalcin. Finally, differences were noted in the expressionof RUNX2 between patients with osteoporosis and controls, as well as between blood and bone samples in the osteoporotic patients. In conclusion, this study addresses osteoporosis as a multifuctorial entity. The provided data could be used as the foundation to be built upon for the development of strategies for more accurate diagnosis and prediction of the fracture risk using acombination of clinical data, BMD values, biochemical markers of bone metabolism and information from the genetic profile of each patient.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Bougioukli, Sofia
- Μπουγιουκλή, Σοφία
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/43595